No replies to this topic

[YOLF]

 

 

Brain imaging also revealed that the drug reduced levels of amyloid plaques in all the dosing groups, and that 81% of participants were judged to be “amyloid negative” in a brain scan after 18 months of treatment.

http://www.sciencema...inventive-trial

 

Apparently alot of people missed this line of the article... Some took it as a failure... There are of course still Tau aggregates to be handled and perhaps side effects to be ameliorated.